Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Baxter, Covidien, Gilead: Examining the Strongest Names in the Strongest Sector


Currently the health care sector as a whole is rated a strong buy and is not overbought.

INYANVILLE ORIGINAL is taking a look at the strongest sector right now: health care. Currently the sector as a whole is rated a Strong Buy (5) and is not overbought.

Below we have the largest components in the Financial Select Sector SPDR ETF (NYSEARCA:XLV). Only one name, Gilead Sciences (NASDAQ:GILD), is in our strongest health care ratings. Merck (NYSE:MRK) and Eli Lilly (NYSE:LLY) were recently on the list as well. ETFs are great utilities to spread out your risk and gain exposure to a sector, but if you are looking for outperformance, ETFs are not the best place to invest. The only two names in the XLV that are not Strong Buys are UnitedHealth Group (NYSE:UNH) (which we have rated as a Buy) and Bristol Myers Squibb (NYSE:BMY) (which is rated a Hold). has identified the five strongest health care names: Baxter International (NYSE:BAX), Covidien (NYSE:COV), PerkinElmer (NYSE:PKI), Thermo Fisher Scientific (NYSE:TMO) and Gilead Sciences. We recently removed Merck and Eli Lilly from the list of the top five strongest. Let's take a closer look at Merck, Baxter, Gilead, Covidien, and Eli Lilly.

Click to enlarge
< Previous
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos